责任编辑：AI观察员 近年来，无糖茶行业发展火热，各大品牌纷纷布局相关产品。维他奶国际也推出了自己的无糖茶产品。 对于无糖茶业务规划，维他奶国际表示，公司的无糖茶系列在中国香港市场有良好表现，可为中国内地 无糖茶发展模式提供参考。"未来，我们会继续根据消费者需求和期望进行产品开发、创新和布局，茶 饮新品将凭借上乘风味和品质为业务增值。" 维他奶国际集团执行主席罗友礼在业绩发布会上提到，2024/2025 财政年度，大众消费模式发生改变， 对价格日趋敏感。过去下半财年，中国内地市场柠檬茶价格有一定幅度下降，目前减价幅度已稳定，定 价已具备竞争力，未来公司在中国内地市场不会再降价。他还指出，在未来一年，维他奶在植物奶及即 饮茶产品类别增长放缓等因素，或为业务带来短期挑战。但长远来看，集团坚信自身实力，将致力逐步 提升收入及盈利能力。 展望新的财年，维他奶国际计划进一步加强销售执行，增加每个销售网点的销售额，并提高产品供应 量。面对外围环境挑战加剧以及各产品类别增长放缓，集团目标是通过扩大植物奶及即饮茶等核心产品 类型的市场份额，维持所有营运单位的业务规模及盈利能力，尤其重视中国内地市场的发展。与此同 时，集团还将 ...

Core Insights - Vitasoy International Group Limited reported a revenue of HKD 6.274 billion for the fiscal year 2024/2025, reflecting a 1% year-on-year growth, while profit attributable to equity holders surged by 102% to HKD 235 million [1] - The company aims to enhance sales execution and increase product supply in the new fiscal year [1] Group 1: Financial Performance - Revenue from mainland China reached HKD 3.363 billion, with a 1% year-on-year growth excluding exchange rate effects, and a 2% increase in the second half of the fiscal year [1] - Operating profit in mainland China was HKD 311 million, showing a 42% year-on-year growth excluding exchange rate effects, attributed to improved sales strategies and operational efficiency [1] Group 2: Market Dynamics - In Australia, Vitasoy's business experienced continuous sales growth and reduced operating losses, with a 5% revenue increase in local currency for the Australia and New Zealand segment [2] - The operating loss for the Australia and New Zealand business decreased by 4% to AUD 15 million [2] Group 3: Product Development and Consumer Trends - Vitasoy has launched its own sugar-free tea products in response to the growing demand in the sugar-free tea market, with positive market performance in Hong Kong [2] - The company plans to continue product development and innovation based on consumer needs and expectations, focusing on enhancing the value of its tea beverage offerings [2] Group 4: Pricing Strategy - The company observed a shift in consumer behavior towards price sensitivity, leading to a price reduction in lemon tea in mainland China, which has now stabilized [2] - Vitasoy will not further reduce prices in the mainland market and anticipates short-term challenges due to slowing growth in plant-based milk and ready-to-drink tea categories [2]

Group 1 - The core viewpoint of the article highlights Vitasoy International's revenue growth of 1% for the fiscal year 2024/2025, reaching HKD 6.274 billion, driven by strong performance in core products in mainland China and stable results in Hong Kong [1] - The company's net profit attributable to equity holders surged by 102% to HKD 235 million, attributed to improved sales execution in mainland China and strong performance in Hong Kong [1] - The company plans to distribute a final dividend of HKD 0.102 per share, pending approval at the annual general meeting on August 25, 2025, resulting in a total dividend of HKD 0.142 per share for the fiscal year 2024/2025, compared to HKD 0.077 per share in the previous fiscal year [1] Group 2 - Vitasoy International aims to maintain business scale and profitability across all operating units while focusing on expanding market share in core products like plant-based milk and ready-to-drink tea, particularly in mainland China [2] - The company acknowledges challenges from a worsening external environment and slowing growth in various product categories but remains confident in its core product portfolio and health innovation series to capture growth opportunities [2]